All In Biotech

Drug Trial Radar · NCT04871282

A Study of AL102 in Patients With Progressing Desmoid Tumors

RINGSIDE: A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients With Progressing Desmoid Tumors

Last checked: Nov 20, 2026Latest source record: Jun 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 198 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

198

Actual

Start

Sep 1, 2021

Primary completion

Dec 3, 2025

Study completion Dec 2026

Sponsor

Lead sponsor
Immunome, Inc.Industry
Sponsor type
Industry
First posted
May 4, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The current study is designed to evaluate the efficacy and safety of AL102 in patients with progressive desmoid tumors.

Conditions

  • Desmoid
  • Desmoid Tumor

Interventions

  • AL102Drug

    AL102 is an inhibitor of gamma secretase-mediated Notch signaling.

  • PlaceboOther

    Placebo to match AL102

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Safety and Tolerability - Adverse EventsTime frame: Approximately 1.5 years
  2. Part B: Progression free survival (PFS)Time frame: Approximately 2 years

Locations

53 sites in 11 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Pheonix, Arizona

  • City of Hope

    Duarte, California

  • Sarcoma Oncology Research Center

    Santa Monica, California

  • University of California at Los Angeles Hematology/Oncology

    Santa Monica, California

  • Stanford University Medical Center

    Stanford, California

  • Mayo Clinic

    Jacksonville, Florida

  • NorthShore University Health System

    Evanston, Illinois

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • Jefferson City Medical Group

    Jefferson City, Missouri

  • Washington University

    St Louis, Missouri

  • Columbia University Irving Medical Center

    New York, New York

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • Levine Cancer Institute

    Charlotte, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Ohio State University Wexner Medical Center

    Columbus, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • Jefferson University Hospital

    Philadelphia, Pennsylvania

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania

  • University of Pittsburgh Medical Center, Hillman Cancer Center

    Pittsburgh, Pennsylvania

  • UTSW Simmons Cancer Center

    Dallas, Texas

  • MD Anderson Cancer Center

    Houston, Texas

  • Fred Hutchinson Cancer Center

    Seattle, Washington

  • Chris O'Brien Lifehouse

    Camperdown, New South Wales, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Adelaide Cancer Centre

    Kurralta Park, South Australia, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, Australia

  • Universitair Ziekenhuis

    Ghent, Belgium

  • Universitaire Ziekenhuizen Leuven

    Leuven, Belgium

  • Helios Klinikum Berlin-Buch

    Berlin, Germany

  • Mannheim university medical center

    Mannheim, Germany

  • Oncology Institute Barzilai Medical Center

    Ashkelon, Israel

  • Rambam MC

    Haifa, Israel

  • Hadassah University Hospital - Ein Kerem

    Jerusalem, Israel

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • IRCCS Istituto Ortopedico Rizzoli

    Bologna, Italy

  • IRCCS Fondazione Istituto Nazionale dei Tumori

    Milan, Italy

  • Campus Bio-Medico University Hospital

    Rome, Italy

  • The Netherlands Cancer Institute

    Amsterdam, Netherlands

  • Leiden University Medical Center

    Leiden, Netherlands

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.